stem cell oversight

FTC returns half a mill to consumers of “deceptively marketed amniotic stem cell therapy”

Bryn-Jarald-Henderson-D.O.-

There’s a lot of questionable “stem cell” injections these days involving purported amniotic stem cell or other perinatal (birth-related) material. Regulators are taking note including the FTC, which took some unprecedented action last year on this front. Now the FTC has announced that more than half a million $USD have been returned to consumers who …

FTC returns half a mill to consumers of “deceptively marketed amniotic stem cell therapy” Read More »

My new Cell Stem Cell piece: too much carrot & not enough stick on stem cell oversight

carrot-and-sticks

I have a new Cell Stem Cell piece out today that aims to take stock of today’s stem cell regulatory oversight in the U.S., Japan, and elsewhere including Australia, Canada and India. I use a carrot and stick metaphor for encouraging legit research and taking regulatory action on serious non-compliant activities, respectively. Where is stem cell …

My new Cell Stem Cell piece: too much carrot & not enough stick on stem cell oversight Read More »

September FDA stem cell meeting looks to be big debate

FDA-draft-guidance

That much-anticipated public FDA stem cell meeting that was postponed from April will now take place in September and will have a much larger array of diverse speakers. Many more voices at an FDA stem cell meeting are collectively a good thing, but delay is not. The large and growing U.S. stem cell clinic industry makes …

September FDA stem cell meeting looks to be big debate Read More »